Pfizer and These Stocks Cheer 52-Week Highs as Dow Climbs Higher

Pfizer (NYSE:PFE): Mylan (NASDAQ:MYL) and Pfizer (NYSE:PFE) announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Teva that will resolve pending patent litigation related to its abbreviated new drug application for a generic epinephrine auto-injector. According to the terms of the settlement, Teva (NASDAQ:TEVA) may launch a generic epinephrine auto-injector covered by its ANDA on June 22, 2015 or earlier under certain circumstances, subject to receipt of approval from the FDA. Teva currently does not have tentative approval from the FDA for its epinephrine auto-injector product. The shares closed at $23.06, up $0.18 or 0.79% on the day. They have traded in a 52-week range of $16.63 to $22.98.

Realty Income Corp. (NYSE:O): Reported Q1 revenue $114.7M versus consensus $114.87M. Q1 FFO includes a non-cash preferred stock redemption charge of 3c per share. The shares closed at $39.41, down $0.05 or 0.13% on the day. They have traded in a 52-week range of $27.93 to $39.56.

Onyx Pharmaceuticals (NASDAQ:ONXX): Onyx Pharmaceuticals announced that the U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee will review the company’s new drug application for carfilzomib for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior therapies. ODAC will review carfilzomib at its meeting on June 20. The Prescription Drug User Fee Act date for completion of review by the FDA is July 27. The shares closed at $47.02, down $0.31 or 0.65% on the day. They have traded in a 52-week range of $27.17 to $47.58.

O’Reilly Automotive (NASDAQ:ORLY): Says gas prices have decreased a little over the past few weeks, but they remain high and the company feels that this could negatively impact miles driven and consumer spending. The shares closed at $102.64, up $6.02 or 6.23% on the day. They have traded in a 52-week range of $56.25 to $98.09.

Osi Systems (NASDAQ:OSIS): OSI Systems’ Healthcare division, Spacelabs Healthcare, has been awarded an approximate $3.5M contract from a Minnesota healthcare system for patient monitoring and networking solutions . The shares closed at $64.91, up $1.92 or 3.05% on the day. They have traded in a 52-week range of $31.00 to $64.89.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.